Key Takeaways CNC's Q2 earnings estimate of 68 cents per share reflects a 71.9% drop from the prior-year quarter. Premium revenues are projected to rise 14% amid growth in the Commercial Marketplace business. We expect medical costs to surge 17.8% year over year, squeezing CNC's overall margins.Centene Corporation (CNC) is scheduled to release second-quarter 2025 results on July 25, before the opening bell. The Zacks Consensus Estimate for earnings is pegged at 68 cents per share, which indicates a 71.9% ...

NEW YORK, July 23, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Centene Corporation ("Centene" or the "Company")(NYSE: CNC). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll- free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased. The class action concerns whether Centene and certain of its off ...

SAN DIEGO, July 23, 2025 (GLOBE NEWSWIRE) -- Robbins Geller Rudman & Dowd LLP announces that the Centene class action lawsuit – captioned Lunstrum v. Centene Corporation, No. 25-cv-05659 (S.D.N.Y.) – seeks to represent purchasers or acquirers of Centene Corporation (NYSE: CNC) securities and charges Centene and certain of Centene’s top executives with violations of the Securities Exchange Act of 1934. If you suffered substantial losses and wish to serve as lead plaintiff of the Centene class action lawsuit, ...

NEW YORK, July 22, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Centene Corporation ("Centene" or the "Company") (NYSE: CNC) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Centene investors who were adversely affected by alleged securities fraud between December 12, 2024 and June 30, 2025. Follow the link below to get more information and be contacted by a member of our team: https://zlk.com/pslra-1/centene-corporation-lawsuit ...

Wall Street analysts forecast that Centene (CNC) will report quarterly earnings of $0.68 per share in its upcoming release, pointing to a year-over-year decline of 71.9%. It is anticipated that revenues will amount to $44.27 billion, exhibiting an increase of 11.1% compared to the year-ago quarter.Over the last 30 days, there has been a downward revision of 57.3% in the consensus EPS estimate for the quarter, leading to its current level. This signifies the covering analysts' collective reconsideration of t ...

NEW YORK, July 22, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Centene Corporation ("Centene" or the "Company") (NYSE: CNC) of a class action securities lawsuit.CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Centene investors who were adversely affected by alleged securities fraud between December 12, 2024 and June 30, 2025. Follow the link below to get more information and be contacted by a member of our team:https://zlk.com/pslra-1/centene-corporation-lawsuit-submi ...

诉讼背景 - 领先证券律师事务所Bleichmar Fonti & Auld LLP宣布对Centene Corporation及其部分高管提起集体诉讼 指控其可能违反联邦证券法 [1] - 诉讼依据为《1934年证券交易法》第10(b)和20(a)条款 代表购买Centene证券的投资者发起 案件由美国纽约南区地方法院受理 [2] 公司业务概况 - Centene是一家专注于政府资助医疗计划(如Medicaid和Medicare)的医疗保险公司 同时通过健康保险市场提供平价医疗法案相关保险产品 [3] 财务指引争议 - 2024年12月12日公司发布2025财年指引 称其反映"前所未有的逆风中收益能力的稳定性" [4] - 2025年2月4日因参保人数"超预期"上调指引 4月25日再次以参保率和留存率强劲为由上调指引 [4] - 实际情况是公司主要服务市场的参保增长率低于预期 且疾病发病率(morbidity rates)高于预期 [4] 股价暴跌事件 - 2025年7月1日公司突然撤回先前指引 因独立精算报告显示：在29个服务州中 22个州的市场增长率低于预期 且这些州的发病率显著高于预期 [5] - 消息公布后股价从7月1日的56.65美元/股暴跌至7月2日的33.78美元/股 单日跌幅达40%(22.87美元/股) [5] 律所背景 - 代理律所BFA曾为特斯拉董事会案件追回9亿美元 在Teva制药案中追回4.2亿美元 [8]

LOS ANGELES, July 22, 2025 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Centene Corporation ("Centene" or "the Company") (NYSE: CNC) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.Investors who purchased the Company's securities between December 12, 2024 and June 30, 2025, inclusive (the "Class Period"), ar ...

公司估值 - Centene股票当前交易价格约为账面价值的0.5倍 [1] 市场机会 - 市场出现明显投资机会 Centene被显著低估 [1]

公司动态 - Centene Corporation因涉嫌在2024年12月12日至2025年6月30日期间向投资者发布虚假或误导性声明被集体诉讼 [3] - 公司被指控隐瞒了关于参保率和发病率真实情况的不利事实 导致投资者质疑其公开声明的真实性 [3] - 2025年7月1日公司撤回2025年业绩指引后 股价从56 65美元暴跌至33 78美元 跌幅达40 4% [3] 财务影响 - 根据2025年健康保险市场分析 Centene在22个州的市场增长低于预期 这些州占其市场会员总数的72% [3] - 初步分析显示公司需将此前发布的业绩指引下调约18亿美元 调整后稀释每股收益降至2 75美元 [3] 法律程序 - 集体诉讼登记截止日期为2025年9月8日 股东可通过指定链接提交损失申报 [4] - 参与股东将获得案件生命周期内的投资组合监控服务 无需承担任何费用或义务 [4]